Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $20.8333.
Several analysts have recently issued reports on the company. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. BMO Capital Markets increased their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday, August 25th. Finally, Truist Financial increased their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd.
Get Our Latest Stock Analysis on SBRA
Sabra Healthcare REIT Trading Down 0.4%
SBRA opened at $19.05 on Monday. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.03. The business has a fifty day simple moving average of $18.68 and a 200-day simple moving average of $17.99. The firm has a market cap of $4.57 billion, a P/E ratio of 25.07, a P/E/G ratio of 1.52 and a beta of 0.88. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. During the same period last year, the business posted $0.36 earnings per share. The company's quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were issued a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. SVB Wealth LLC purchased a new position in shares of Sabra Healthcare REIT in the 1st quarter valued at about $34,000. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after purchasing an additional 1,621 shares during the last quarter. Wealth Preservation Advisors LLC purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth about $38,000. EverSource Wealth Advisors LLC grew its holdings in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock worth $47,000 after purchasing an additional 1,536 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in shares of Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after purchasing an additional 1,065 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.
About Sabra Healthcare REIT
(
Get Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.